Abstract
An AML Targeted Duplex Sequencing Assay That Can Detect Measurable Residual Disease (MRD) at a Sensitivity Better Than 0.01% Variant Allele Frequency
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have